| Literature DB >> 28577831 |
Karyn A Goodman1, Brian D Kavanagh2.
Abstract
Many cancers can spread to the liver, often as the sole site of metastatic disease. For properly selected patients with limited hepatic disease and good performance status, an aggressive strategy involving radical local therapy to the site(s) of metastasis offers a chance for extended disease-free survivorship. The development of stereotactic body radiotherapy has inserted radiation therapy into the arsenal of valuable treatment options in this clinical setting. This article summarizes the latest advancements in the use of stereotactic body radiotherapy to treat liver metastases.Entities:
Mesh:
Year: 2017 PMID: 28577831 DOI: 10.1016/j.semradonc.2017.02.004
Source DB: PubMed Journal: Semin Radiat Oncol ISSN: 1053-4296 Impact factor: 5.934